Aeluma (NASDAQ:ALMU) Posts Earnings Results, Beats Estimates By $0.01 EPS

Aeluma (NASDAQ:ALMU – Get Free Report) released its earnings results on Thursday. The company reported ($0.12) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.01, Zacks reports. The company had revenue of $0.57 million during the quarter. Aeluma had a negative return on equity of 18.14% and a negative net margin of 205.31%.

Here are the key takeaways from Aeluma’s conference call:

  • Aeluma said customer discussions in AI datacom have expanded across the value chain, including potential development funding, sample qualification and product opportunities. Management sees the most significant volume ramps emerging in 2028 and beyond, though no specific customer agreements or volumes were disclosed.
  • The company is targeting demand for “slow and wide” optical interconnects with its photodetectors and microemitters, as well as scale-up and scale-out applications with quantum dot lasers. Its gallium-arsenide- and silicon-based approach avoids reliance on constrained indium phosphide substrates and fabs.
  • Aeluma ended the quarter with $53.9 million in cash and no debt. It also agreed to procure an AIXTRON MOCVD system for capacity expansion and development, although management said the tool is not required for near-term commercialization and gave no installation timeline.
  • First-quarter revenue fell to $568,000 from $1.4 million a year earlier, while GAAP net loss widened to $3.8 million from $1.5 million. Adjusted EBITDA loss also increased, reflecting higher spending on headcount, product development and commercialization preparations.

Aeluma Price Performance

NASDAQ:ALMU opened at $6.93 on Friday. The firm’s 50-day moving average price is $10.44 and its 200-day moving average price is $16.07. The company has a market capitalization of $133.87 million, a PE ratio of -13.34 and a beta of 4.52. Aeluma has a 1-year low of $5.87 and a 1-year high of $31.79.

Insider Transactions at Aeluma

In related news, CEO Jonathan Klamkin sold 100,000 shares of the business’s stock in a transaction dated Monday, October 12th. The shares were sold at an average price of $10.53, for a total transaction of $1,053,000.00. Following the sale, the chief executive officer owned 1,126,995 shares of the company’s stock, valued at $11,867,257.35. The trade was a 8.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Steven Denbaars sold 12,500 shares of the business’s stock in a transaction dated Wednesday, August 26th. The stock was sold at an average price of $13.84, for a total transaction of $173,000.00. Following the sale, the director directly owned 357,709 shares in the company, valued at $4,950,692.56. The trade was a 3.38% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 212,500 shares of company stock valued at $2,561,000. 12.78% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ALMU shares. Northland Securities started coverage on Aeluma in a research report on Monday, November 2nd. They issued an “outperform” rating and a $16.00 price objective on the stock. Freedom Broker dropped their price target on Aeluma from $30.00 to $25.00 and set a “buy” rating for the company in a research note on Thursday, September 17th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Aeluma in a report on Thursday, October 15th. Finally, Zacks Research began coverage on shares of Aeluma in a research report on Tuesday, November 3rd. They set a “hold” rating on the stock. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.75.

Read Our Latest Stock Analysis on ALMU

About Aeluma

(Get Free Report)

Aeluma, Inc. develops semiconductor materials and optoelectronic devices using technology designed to integrate compound semiconductors with silicon wafers. Its approach aims to combine the performance of compound semiconductors with the scale and manufacturing advantages of silicon-based processes. The company’s technology is intended for applications in areas such as optical communications, sensing, and other photonics markets. Potential device applications include lasers and photodetectors, which can be used to generate or detect light in electronic systems.

Featured Stories

Earnings History for Aeluma (NASDAQ:ALMU)

Receive News & Ratings for Aeluma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeluma and related companies with MarketBeat.com's FREE daily email newsletter.